Fereshtehnejad, Seyed-Mohammad

Prodromal Parkinson disease subtypes — key to understanding heterogeneity

Berg, D., Borghammer, P., Fereshtehnejad, S.-M., Heinzel, S., Horsager, J., Schaeffer, E., & Postuma, R. B. (2021) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 409

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

Burstein, R., Henry, N. J., Collison, M. L., Marczak, L. B., Sligar, A., Watson, S., Marquez, N., Abbasalizad-Farhangi, M., Abbasi, M., Abd-Allah, F., et al. (2019) · Nature

Global Maternal and Child HealthMaternal and Neonatal Healthcare

Cited by 276

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

Schumacher, A. E., Zheng, P., Barber, R. M., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abbafati, C., Abbas, N., et al. (2025) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Cancer Incidence and Screening

Cited by 209

Cerebral Microbleeds: Different Prevalence, Topography, and Risk Factors Depending on Dementia Diagnosis—The Karolinska Imaging Dementia Study

Shams, S., Martola, J., Granberg, T., Li, X., Shams, M., Fereshtehnejad, S. M., Cavallin, L., Aspelin, P., Kristoffersen-Wiberg, M., & Wahlund, L. O. (2015) · American Journal of Neuroradiology

Intracerebral and Subarachnoid Hemorrhage ResearchDementia and Cognitive Impairment Research

Cited by 132

Dental care utilization in patients with different types of dementia: a longitudinal nationwide study of 58,037 individuals

Fereshtehnejad, S., Garcia‐Ptacek, S., Religa, D., Holmer, J., Buhlin, K., Eriksdotter, M., & Sandborgh‐Englund, G. (2018) · Alzheimer's & Dementia

Dental Health and Care UtilizationDementia and Cognitive Impairment Research

Cited by 81

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry

Enache, D., Fereshtehnejad, S. ‐., Kåreholt, I., Cermakova, P., Garcia‐Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., et al. (2016) · Acta Psychiatrica Scandinavica

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 42

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)

Fereshtehnejad, S.-M., Religa, D., Westman, Lökk, J., Eriksdotter, M., & Aarsland, D. (2013) · Neuropsychiatric Disease and Treatment

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 42

Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL

Panahi, M., Rodriguez, P. R., Fereshtehnejad, S.-M., Arafa, D., Bogdanovic, N., Winblad, B., Cedazo-Minguez, A., Rinne, J., Darreh-Shori, T., Hase, Y., et al. (2020) · Frontiers in Genetics

Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments

Cited by 9